» Authors » Charlotte van Kesteren

Charlotte van Kesteren

Explore the profile of Charlotte van Kesteren including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 628
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Beex-Oosterhuis M, Lau S, van Kesteren C, Verloop S, Grootens K, Faber G, et al.
J Clin Psychopharmacol . 2025 Mar; PMID: 40063713
Purpose/background: Clozapine and norclozapine are highly protein bound. Currently, clozapine is increasingly prescribed once daily (QD). Higher (once daily) doses may theoretically lead to saturation of protein binding of (nor)clozapine,...
2.
Lau C, van Kesteren C, Cao Y, Smeenk R, Daenen L, Janssen J, et al.
Ann Hematol . 2024 Aug; 103(11):4765-4771. PMID: 39129028
Bariatric surgery is increasingly performed to treat severe obesity. As a result of anatomical and physiological changes in the gastrointestinal tract, the pharmacokinetics (PK) of oral drugs can be altered,...
3.
Lau C, van Kesteren C, Smeenk R
Obes Surg . 2024 Apr; 34(5):1778-1785. PMID: 38565826
Background: As metabolic and bariatric surgery (MBS) can alter the pharmacokinetics of drugs, post-bariatric surgery patients may require medication adjustments and monitoring. To improve pharmacotherapy in these patients, we aimed...
4.
Sikking C, Niggebrugge-Mentink K, van der Sman A, Smit R, Bouman-Wammes E, Beex-Oosterhuis M, et al.
Oncologist . 2023 Nov; 29(2):e173-e186. PMID: 37995306
Introduction: Cisplatin-induced nephrotoxicity (CIN) can be prevented by fluid hydration, electrolyte supplementation, or forced diuresis; however, the best way to prevent CIN is still unknown. The aim of this study...
5.
Lau C, van Kesteren C, Smeenk R, Huitema A, Knibbe C
Obes Surg . 2023 Aug; 33(10):3266-3302. PMID: 37594672
Sparse information is available on pharmacokinetic changes of drugs over time after bariatric surgery. By reviewing the literature on the short- and long-term pharmacokinetic changes of drugs, several patterns were...
6.
Lau C, Sbaa O, Smeenk R, van Kesteren C
Eur J Clin Pharmacol . 2022 Dec; 79(2):237-242. PMID: 36512030
Purpose: To enable the use of automatic clinical decision support for pharmacotherapy in patients with bariatric surgery, it is necessary to register the contraindication "bariatric surgery" in the hospital, general...
7.
Beex-Oosterhuis M, Van Gool A, Heerdink E, van Kesteren C, van Marum R
J Clin Psychiatry . 2021 Dec; 83(1). PMID: 34905664
The objective of this systematic review was to provide a critical appraisal of the evidence related to the safety of clozapine for schizophrenia during pregnancy and lactation. PubMed/MEDLINE, Embase, and...
8.
van Doorn L, Crombag M, Rier H, van Vugt J, van Kesteren C, Bins S, et al.
Pharmaceuticals (Basel) . 2021 Jan; 14(1). PMID: 33435449
Changes in body composition are associated with chemotherapy-related toxicities and effectiveness of treatment. It is hypothesized that the pharmacokinetics (PK) of chemotherapeutics may depend on body composition. The effects of...
9.
Niggebrugge-Mentink K, Beex-Oosterhuis M, Ter Horst P, van de Poll M, Dieleman H, van Kesteren C
J Clin Pharm Ther . 2020 Jun; 45(5):1153-1158. PMID: 32533904
What Is Known And Objective: Nephrotoxicity is a frequently occurring side effect of cisplatin, which may be reduced by applying ample hydration. The aim of this study was to determine...
10.
Langenhorst J, Boss J, van Kesteren C, Lalmohamed A, Kuball J, Egberts A, et al.
Br J Clin Pharmacol . 2020 Feb; 86(8):1499-1509. PMID: 32067250
Aim: To develop a semi-mechanistic model, based on glutathione depletion and predict a previously identified intra-individual reduction in busulfan clearance to aid in more precise dosing. Methods: Busulfan concentration data,...